Searchable abstracts of presentations at key conferences in endocrinology

ea0065cc5 | FEATURED CLINICAL CASE POSTERS | SFEBES2019

Pituitary carcinoma with hepatic metastasis hypersecreting ACTH precursors masquerading as Nelson syndrome after bilateral adrenalectomy for refractory Cushing’s syndrome

Dhakshinamoorthy Barkavi , Elsaify Wael , Nag Sath

Pituitary carcinomas are extremely rare accounting for only 0.1%–0.2% of all pituitary tumours. The diagnosis is primarily dependent on aggressive imaging characteristics and high tumour mitotic activity on histology. A 47 year old gentleman with Type 1 Diabetes presented with an apparent non-functioning pituitary macro adenoma which was resected transsphenoidally and followed by EBRT. Initial histology was negative for ACTH. He presented 2 years later with florid Cushing...

ea0059ep81 | Neuroendocrinology and pituitary | SFEBES2018

Secondary resistance to Cabergoline-pitfalls and challenges of managing macroprolactinoma with high dose dopamine agonist therapy

Abdalaziz Altayeb , Nag Satyajit , Dhakshinamoorthy Barkavi

Dopamine agonists (DA) are first line therapy for Prolactinoma which normalises prolactin(PRL) level in 80% of cases at a median weekly dose of 1 mg. An accepted criterion of pharmacological resistance to DA is failure to normalize PRL levels. We report a case of aggressive macroprolactinoma that required 7 mg of Cabergoline to reduce prolactin despite radiological evidence of tumour shrinkage. A 42 year old male presented with a bitemporal field defect. Imaging confirmed an i...

ea0074ncc15 | Highlighted Cases | SFENCC2021

A case report on rare metastic Paraganglioma with SDHB mutation

Dhakshinamoorthy Barkavi , Nag Sath , Ahmad Waquar

Paragangliomas are rare neuroendocrine tumours that originate from neural crest cells and can arise from any autonomic ganglion of the body. This is a challenging entity given the limited therapeutic options. Here, we present a rare case of metastatic Paraganglioma in a patient with a germline pathogenic succinate dehydrogenase subunit B (SDHB) mutation. A 54 year old lady was initially diagnosed with functioning bladder paraganglioma with raised metanephrine and norm...

ea0086p338 | Metabolism, Obesity and Diabetes | SFEBES2022

Unusual late presentation of maturity onset diabetes of young (MODY)

Ahmad Waqar , Khan Irfan , Chohan Muhammad , Dhakshinamoorthy Barkavi , Arutchelvam Vijayaraman

Background: Maturity-onset diabetes of the young (MODY) is a group of 13 monogenic forms of diabetes transmitted in an autosomal dominant pattern and is characterized by a primary defect in pancreatic β-cell function. This disease has an early onset, usually before 25 years of age. It may present with mild asymptomatic hyperglycemia with progressive development to clinical diabetes mellitus. First-line treatment relies on sulphonylureas or insulin according to MODY subtyp...

ea0077p158 | Bone and Calcium | SFEBES2021

Immobilization induced hypercalcemia

Khan Irfan Iqbal , Ahmad Waqar , Tahir Chohan Muhammad , Aung Aung , Dhakshinamoorthy Barkavi , Nag Satyajit

Introduction: Immobilization hypercalcemia is uncommon condition associated with limited movements following brain and spinal cord lesions. Immobilization results in stimulation of osteoclastic bone resorption hypercalciuria and hypercalcemia.Case report: 57 year female, Background of Breast Cancer (Treated with Skin sparing mastectomy and adjuvant radiotherapy) admitted following large subdural hematoma leading to craniotomy and evacuation of hematoma. ...